Axsome Therapeutics (AXSM) ROA US GAAP (year values)

2022 2022 2023 2024 2025   LTM ? CAGR 5 years ?
ROA, % ? -56.5% -56.5% -40.7% -50.5% -26.6%   -26.4%  
Changes by years, y/y, % +92pp 0pp +16pp -10pp +24pp     -14.1%

Axsome Therapeutics. ROA, %

Axsome Therapeutics. ROA, changes, pp

Axsome Therapeutics (AXSM) ROA US GAAP (quarter values)

2025Q1 2025Q2 2025Q3 2025Q4 2026Q1   LTM ?
ROA, % ? -46.6% -38.6% -34.3% -26.6% -26.4%   -26.4%
Changes by years, y/y, % +8pp +18pp +21pp +24pp +20pp    
Changes by quarters, q/q, % +4pp +8pp +4pp +8pp +0pp    

Axsome Therapeutics. ROA, %

Axsome Therapeutics. ROA, changes, pp

Axsome Therapeutics. ROA, changes, pp